Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Medpace Holdings Inc
MEDP | US
393.42
USD-115.04
-22.63%
MEDP | US
Loading StockChartView...
About Medpace Holdings Inc
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
23/04/2026
Close
393.42
Open
375.15
High
407.61
Low
373.00
Medpace Holdings Inc. provides clinical research-based drug and medical device development services in North America Europe and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical biotechnology and medical device industries; and development plan design coordinated central laboratory project management regulatory affairs clinical monitoring data management and analysis pharmacovigilance new drug application submissions and post-marketing clinical support services. In addition it offers bio-analytical laboratory services clinical human pharmacology imaging services and electrocardiography reading support for clinical trials. Medpace Holdings Inc. was founded in 1992 and is based in Cincinnati Ohio.
View LessMEDP | US
Risk
85.2
Sharpe
0.49
Luna's Score
48/100
Recommendation
Hold
Luna says (MEDP | US)
What's Working
Largecap (10B - 200B USD)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High Current Volume and Negative 1-Day Return
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
112.3%1 month
85.2%3 months
64.5%6 months
51.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
33.43
Fwd. PE
26.04
Price to book
13.92
Debt to equity
0.20
Debt to assets
0.08
Ent. to EBITDA
25.03
Ent. to rev.
5.05
PEG
1.58
Other Fundamentals
EBITDA
409.52M
MarketCap
12.20B
MarketCap(USD)
12.20B
Div. yield
-
Op. margin
19.91
Erngs. growth
42.50
Rev. growth
14.60
Ret. on equity
58.86
Short ratio
3.07
Short perc.
6.00
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
157.19
Range1M
157.19
Range3M
248.45
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
4.08
Price X volume
615.55M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 25.03 | 12.67 | Expensive |
| Ent. to Revenue | 5.05 | 44.00 | Cheaper |
| PE Ratio | 33.43 | 40.09 | Par |
| Price to Book | 13.92 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 64.53 | 59.59 | Par |
| Debt to Equity | 0.20 | -14.36 | Expensive |
| Debt to Assets | 0.08 | 0.34 | Cheaper |
| Market Cap | 12.20B | 13.71B | Par |
